Maedi-Visna / Ovine Progressive Pneumonia (OPP)

Maedi-Visna, also known as Ovine Progressive Pneumonia (OPP), is a chronic, progressive viral disease caused by a lentivirus that affects sheep and occasionally goats worldwide. The disease derives its name from Icelandic words where 'maedi' means labored breathing and 'visna' means wasting, accurately describing the two primary clinical presentations of this devastating condition. This retrovirus belongs to the same family as caprine arthritis encephalitis virus (CAEV) in goats and shares similarities with human immunodeficiency virus (HIV) in its mechanism of action and persistence within the host.

Maedi-Visna affects sheep populations globally, with prevalence varying significantly by region and management practices. In some countries, infection rates in commercial flocks can exceed 50 percent, while intensive eradication programs in others have significantly reduced disease presence. The virus targets multiple organ systems, including the lungs, central nervous system, mammary glands, and joints, leading to various clinical manifestations that may appear individually or in combination. Both meat and wool sheep breeds are susceptible, though some breed differences in disease resistance have been documented.

The economic impact of Maedi-Visna on sheep production enterprises is substantial and multifaceted. Infected animals experience reduced longevity, decreased wool production, impaired milk yield, poor body condition, and increased susceptibility to secondary infections. Lamb survival rates decline when ewes have mastitis caused by the virus, and breeding programs may be compromised when valuable genetics cannot be utilized due to positive disease status. International trade restrictions on sheep from infected flocks add another layer of economic consequence for producers seeking to market animals across borders.

Unfortunately, there is currently no cure or effective treatment for Maedi-Visna, and no vaccines are available to prevent infection. Once sheep become infected, they remain carriers for life and can transmit the virus to other susceptible animals. Early detection through regular testing programs is critical for implementing control measures and preventing widespread flock infection. Producers who maintain rigorous testing protocols and cull positive animals can successfully maintain disease-free status, protecting both animal welfare and enterprise profitability over the long term.

Maedi-Visna is caused by a lentivirus belonging to the family Retroviridae, the same viral family that includes caprine arthritis encephalitis virus in goats and human immunodeficiency virus in humans. This small ruminant lentivirus (SRLV) is an RNA virus that integrates its genetic material into the host cell DNA, establishing lifelong infection that the immune system cannot eliminate. The virus replicates slowly within monocytes and macrophages, leading to the characteristically prolonged incubation period that can extend for months to years before clinical signs become apparent.

Genetic factors play a significant role in determining susceptibility to Maedi-Visna infection and disease progression. Research has identified specific gene polymorphisms associated with resistance to lentivirus infection in sheep, particularly variations in the TMEM154 gene. Animals carrying certain haplotypes of this gene demonstrate significantly reduced susceptibility to infection, providing opportunities for genetic selection as part of control programs. However, genetic resistance does not confer complete protection, and even resistant animals can become infected under high exposure conditions.

Environmental and management factors substantially influence transmission dynamics and disease prevalence within flocks. Close confinement housing, particularly during winter months or lambing seasons, dramatically increases transmission risk as the virus spreads primarily through respiratory secretions. Poor ventilation in barns concentrates viral particles in the air, facilitating aerosol transmission between animals. Commingling of infected and susceptible sheep, whether through purchases, shared grazing, or show participation, introduces the virus to previously negative flocks.

The primary risk factors for Maedi-Visna infection include age, with adult sheep over two years being most commonly diagnosed due to the long incubation period. Intensive production systems with high stocking densities favor virus transmission compared to extensive range operations. Lambs born to infected ewes face significant risk of vertical transmission through ingestion of virus-laden colostrum and milk, making maternal infection status a critical determinant of offspring infection. Shared equipment, transport vehicles, and contaminated premises can contribute to indirect transmission between groups.

The pathophysiology of Maedi-Visna involves viral replication within cells of the monocyte-macrophage lineage, triggering chronic inflammatory responses in target organs. In the lungs, persistent viral infection stimulates lymphoid hyperplasia and interstitial pneumonia, progressively reducing functional lung capacity over years. Nervous system involvement occurs when infected cells cross the blood-brain barrier, initiating demyelinating lesions that cause the progressive paralysis associated with visna. The immune response itself contributes to tissue damage, as the chronic inflammatory infiltrates cause fibrosis and organ dysfunction even as they fail to eliminate the virus.

Early warning signs of Maedi-Visna infection are often subtle and easily overlooked during routine flock observations. Affected sheep may exhibit mild exercise intolerance, lagging behind the flock during movement, or showing slightly increased respiratory effort after exertion. Weight loss may be gradual and initially attributed to poor nutrition, parasitism, or other common conditions. Some infected animals remain clinically normal for years while silently transmitting the virus to flockmates, making early identification without testing extremely challenging for producers.

The clinical presentation of Maedi-Visna varies depending on which organ systems are primarily affected, though multiple manifestations can occur simultaneously in the same animal. The pulmonary form, maedi, is characterized by progressive respiratory difficulty that worsens over months to years. Affected sheep develop increasingly labored breathing, with extended neck posture, flared nostrils, and visible abdominal effort during respiration. Open-mouth breathing may occur during advanced stages, and affected animals often seek isolation from the flock and avoid physical exertion.

Behavioral changes associated with Maedi-Visna reflect the systemic nature of infection and progressive organ damage. Infected sheep often demonstrate decreased appetite and reduced feed intake, leading to progressive weight loss despite adequate nutrition availability. Social isolation becomes more pronounced as the disease progresses, with affected animals separating themselves from the flock and spending increased time lying down. Reduced alertness and responsiveness to environmental stimuli may be observed, particularly in animals with nervous system involvement.

Physical signs of Maedi-Visna extend beyond respiratory manifestations to include changes in multiple body systems. The mammary form presents as indurative mastitis, where the udder becomes firm and nodular with dramatically reduced milk production. Affected ewes may fail to adequately nurse their lambs, leading to poor lamb growth and survival. The arthritic form causes joint swelling, particularly in the carpal and tarsal joints, leading to progressive lameness and reluctance to move. Nervous system involvement produces progressive posterior weakness and ataxia that may eventually lead to paralysis.

Symptom progression in Maedi-Visna follows a characteristic pattern of gradual deterioration over months to years, punctuated by periods of apparent stability. Initial respiratory signs progress from mild exercise intolerance to resting dyspnea as functional lung tissue diminishes. Body condition steadily declines despite appropriate nutrition, and wool quality may deteriorate with breaks in the fiber and reduced fleece weight. Animals surviving to advanced stages exhibit severe cachexia, marked respiratory distress, and inability to maintain normal activities.

Emergency symptoms requiring immediate veterinary intervention include severe respiratory distress with cyanosis of mucous membranes, complete recumbency with inability to rise, and signs of secondary bacterial pneumonia such as fever and purulent nasal discharge. Though Maedi-Visna itself is not treatable, secondary complications may be addressed, and humane euthanasia should be considered when quality of life is severely compromised. Animals exhibiting rapid deterioration, persistent recumbency, or apparent suffering should be evaluated promptly for appropriate end-of-life decisions.

Clinical examination of sheep suspected of Maedi-Visna involves thorough physical assessment focusing on the respiratory system, udder, joints, and neurological function. Auscultation of the lungs typically reveals increased bronchial sounds, crackles, and areas of reduced air movement as the disease progresses. Palpation of the udder may detect the characteristic firm, nodular changes of indurative mastitis, while examination of the joints may reveal non-painful swelling of the carpal or tarsal areas. Neurological assessment should evaluate gait, proprioception, and spinal reflexes to detect early nervous system involvement.

Diagnostic testing for Maedi-Visna relies primarily on serological detection of antibodies against the virus, as direct viral isolation is technically challenging and not routinely available. The agar gel immunodiffusion (AGID) test has historically been the standard diagnostic method and remains useful for flock screening programs. Enzyme-linked immunosorbent assay (ELISA) testing offers higher sensitivity and allows for automated processing of large sample numbers, making it suitable for extensive testing programs. Polymerase chain reaction (PCR) testing can detect viral genetic material directly but is less commonly used for routine diagnosis due to intermittent viral shedding and cost considerations.

Differential diagnosis of Maedi-Visna requires consideration of other conditions producing similar clinical signs in sheep. Respiratory disease may be confused with ovine pulmonary adenocarcinoma (jaagsiekte), bacterial pneumonia, lungworm infestation, or caseous lymphadenitis affecting thoracic lymph nodes. The nervous form requires differentiation from scrapie, listeriosis, pregnancy toxemia, polioencephalomalacia, and spinal cord trauma or abscessation. Mastitis must be distinguished from bacterial udder infections, while joint involvement may resemble bacterial arthritis, footrot complications, or degenerative joint disease.

Herd-level diagnostic approaches are essential for understanding Maedi-Visna prevalence and implementing effective control programs. Systematic testing of all animals over one year of age provides baseline prevalence data and identifies infected individuals for removal. Testing should be repeated at regular intervals, typically every six to twelve months, to detect animals that have seroconverted since previous testing. Strategic sampling of high-risk groups, such as purchased animals or offspring of known positive dams, can improve detection efficiency when resources are limited. Necropsy examination of suspect animals provides definitive diagnosis through characteristic histopathological findings in affected organs, including lymphoid hyperplasia in lungs and demyelinating lesions in the central nervous system.

Emergency and immediate treatment options for Maedi-Visna are limited because no antiviral medications effectively eliminate the lentivirus once infection is established. When animals present with acute respiratory distress, supportive measures may provide temporary relief while longer-term management decisions are made. Reducing environmental stressors, providing adequate ventilation, and minimizing handling can decrease respiratory demand in affected animals. Anti-inflammatory medications may reduce inflammation and temporarily improve comfort, though they do not address the underlying viral infection or halt disease progression.

Medical management of Maedi-Visna focuses on treating secondary complications and maintaining quality of life for as long as reasonably possible. Bacterial pneumonia secondary to compromised lung defenses can be addressed with appropriate antibiotic therapy, though producers must strictly observe withdrawal times for meat and milk from food-producing animals. Nutritional support through high-quality, easily digestible feed can help maintain body condition in animals with reduced appetite. Pain management for arthritic manifestations may include non-steroidal anti-inflammatory drugs, again with careful attention to withdrawal periods and veterinary guidance.

Surgical options play no role in Maedi-Visna treatment, as the systemic and progressive nature of viral infection cannot be addressed through surgical intervention. However, supportive surgical procedures might occasionally be needed to address unrelated conditions in infected animals that are being maintained for specific purposes. Any surgical interventions in Maedi-Visna positive animals should consider the guarded long-term prognosis and the cost-benefit analysis of invasive treatment in animals that cannot be cured of their underlying viral infection.

Supportive care for sheep with clinical Maedi-Visna emphasizes comfort and quality of life considerations. Providing easily accessible food and water reduces energy expenditure for debilitated animals. Soft, dry bedding helps prevent decubital ulcers in animals with reduced mobility. Protection from environmental extremes of temperature and weather decreases respiratory and metabolic stress. Regular monitoring for signs of suffering or deterioration guides decisions about continued care versus humane euthanasia.

Herd treatment protocols for Maedi-Visna center on test-and-cull strategies rather than therapeutic interventions. Identifying and removing seropositive animals from the flock interrupts transmission and progressively reduces infection pressure. Replacement animals should be sourced only from tested-negative flocks with documented negative status over time. Offspring of positive dams may be removed at birth and raised on colostrum and milk from negative ewes or artificial milk replacer to prevent vertical transmission. These management approaches, while not treating individual animals, address the disease at the population level.

Treatment decisions for Maedi-Visna inevitably involve economic considerations and production goals that influence individual animal management. Valuable breeding stock that tests positive may be maintained in isolation for limited genetic use while preventing transmission to other animals. Commercial animals with clinical disease typically represent a net economic loss if maintained for prolonged treatment attempts that cannot change the ultimate outcome. Culling decisions should balance animal welfare considerations, economic impacts, and the risk of continued transmission to susceptible flockmates. Veterinary consultation helps producers navigate these complex decisions within the context of their specific operation goals and resources.

Recovery from Maedi-Visna infection is not possible because the lentivirus establishes permanent integration into host cell DNA, persisting for the lifetime of the infected animal. Unlike many viral infections where the immune system eventually clears the pathogen and the animal returns to normal health, sheep infected with Maedi-Visna remain persistently infected and infectious to others. The progressive nature of organ damage means that clinical signs, once apparent, worsen over time rather than resolving. This reality fundamentally shapes management expectations and defines Maedi-Visna as a condition requiring control rather than cure.

Post-detection care and monitoring of Maedi-Visna positive animals depends entirely on the producer's management decisions regarding infected individuals. Animals selected for immediate culling require no extended monitoring but should be handled humanely through appropriate slaughter or euthanasia procedures. Animals maintained for limited breeding purposes or for research require regular monitoring for disease progression and quality of life assessment. Body condition scoring, respiratory evaluation, and assessment of udder, joint, and neurological function should be performed at regular intervals to guide ongoing management decisions.

Prognostic factors for Maedi-Visna relate to disease progression timeline rather than recovery potential. Animals identified through testing before clinical signs develop may remain apparently healthy for months to years before disease manifestations appear. Younger animals at the time of infection detection potentially have longer periods before clinical disease, though this varies substantially between individuals. Animals with detectable clinical signs have progressed further in disease course and typically have shorter remaining functional lifespans. The severity and combination of organ system involvement influences how quickly quality of life deteriorates.

Return to production considerations for Maedi-Visna positive sheep must acknowledge that infected animals pose ongoing transmission risks to negative flockmates. Maintaining positive animals within a production flock perpetuates infection pressure and undermines control efforts regardless of how healthy infected individuals appear. Milk from infected ewes should not be fed to lambs intended for breeding stock in negative flocks due to transmission risk. Positive animals in terminal commercial operations may complete their production cycle before slaughter if strictly separated from breeding stock, but integration back into clean breeding populations is not advisable regardless of apparent health status.

Vaccination protocols for Maedi-Visna prevention do not exist because no effective vaccines have been developed against this lentivirus despite decades of research effort. The virus's integration into host DNA, its ability to mutate and evade immune responses, and its persistence within immune cells that should destroy it present formidable obstacles to vaccine development. Current prevention strategies rely entirely on management practices designed to prevent virus introduction and interrupt transmission within established flocks. Producers should not assume that future vaccination will provide an alternative to current biosecurity-focused prevention approaches.

Biosecurity measures form the cornerstone of Maedi-Visna prevention in sheep flocks. Closed flock management, where no outside sheep are introduced, provides the most reliable protection for negative flocks. When new animals must be acquired, sourcing exclusively from flocks with documented long-term negative testing history reduces introduction risk. Quarantine of all incoming animals with serological testing before flock integration adds another layer of protection. Avoiding contact with sheep of unknown status at shows, sales, and shared grazing areas prevents potential exposure to infected animals.

Nutritional prevention plays no direct role in Maedi-Visna control because the condition results from viral infection rather than nutritional deficiency or imbalance. However, maintaining excellent nutrition supports overall immune function and animal health, potentially slowing disease progression in subclinically infected animals. Ensuring adequate trace mineral nutrition, particularly selenium and copper within species-safe ranges, supports immune competence. Avoiding nutritional stressors that might trigger clinical disease expression in subclinically infected animals benefits overall flock health management.

Management practices that reduce transmission risk include avoiding close confinement housing when possible, ensuring excellent ventilation in enclosed facilities, and maintaining lower stocking densities that reduce aerosol transmission opportunities. Lambing management significantly impacts vertical transmission rates, with removal of lambs from positive dams before nursing and feeding of virus-free colostrum interrupting dam-to-lamb transmission. Equipment sanitation between animal groups, though the virus is relatively fragile in the environment, follows good general biosecurity principles.

Quarantine and testing protocols provide the framework for maintaining negative status and progressively eliminating infection from positive flocks. All new animals entering a property should be quarantined for a minimum of 30 days with serological testing at both arrival and end of quarantine before joining the main flock. Whole-flock testing annually or semiannually identifies new seroconversions and maintains awareness of flock status. Test-and-remove programs conducted repeatedly over several years can successfully eliminate Maedi-Visna from infected flocks, though this requires sustained commitment and rigorous execution. Participation in formal accreditation programs provides external validation of negative status for flocks marketing breeding stock or replacing animals.

Daily management and monitoring of sheep flocks for Maedi-Visna requires consistent attention to animal health indicators that might reveal clinical disease. Observing respiratory effort during normal activities and after exertion helps identify early pulmonary involvement. Monitoring body condition through regular hands-on assessment detects gradual weight loss that visual observation alone might miss. Watching for animals that separate from the flock, demonstrate reduced appetite, or show decreased activity identifies individuals warranting closer examination. Daily observation during feeding provides an efficient opportunity to assess flock health without additional handling.

Housing and environmental management significantly influence Maedi-Visna transmission dynamics within infected or at-risk flocks. Maximizing ventilation in enclosed housing reduces viral particle concentration in the air and decreases aerosol transmission between animals. Providing adequate space per animal reduces close contact and respiratory exposure opportunities. Outdoor housing and extensive grazing systems inherently provide lower transmission pressure than confined operations. If enclosed housing is necessary, ensuring separate airspace for different animal groups limits transmission between management units.

Herd health programs addressing Maedi-Visna must integrate testing and management decisions into overall flock health protocols. Establishing baseline prevalence through initial whole-flock testing defines the scope of the challenge and informs program design. Regular testing intervals, typically annually or semiannually, track program progress and identify new infections requiring attention. Coordinating Maedi-Visna testing with other routine health procedures such as vaccination, deworming, and foot care improves efficiency and reduces animal handling events. Working with a veterinarian experienced in sheep production ensures appropriate testing strategies and interpretation of results.

Record keeping and monitoring systems support informed decision-making for Maedi-Visna control programs. Individual animal identification enables tracking of test results, lineage, and clinical observations over time. Recording test dates and results for each animal creates a historical record essential for program evaluation and purchasing decisions by potential buyers. Documenting which animals have been removed due to positive status helps assess program progress. Electronic record systems designed for livestock operations facilitate data management and analysis, though paper records adequately serve smaller operations with consistent documentation practices.

Economic considerations profoundly influence Maedi-Visna management decisions at the individual animal and whole-flock levels. Calculating the costs of testing programs against the losses from disease provides justification for prevention investments. Estimating the production losses from infected animals, including reduced longevity, decreased milk production, lamb losses, and culling of breeding stock, quantifies disease impact in financial terms. Premium markets for Maedi-Visna negative breeding stock can offset control program costs and reward producers who maintain negative flocks. Producers should evaluate their specific market position, operation size, and production goals when designing economically sustainable Maedi-Visna management programs.

All sheep breeds are susceptible to Maedi-Visna infection, and the virus does not discriminate based on wool type, production purpose, or geographic origin. However, research has identified genetic variation in susceptibility that offers opportunities for selective breeding as part of comprehensive control programs. Studies have documented polymorphisms in the TMEM154 gene associated with significantly reduced susceptibility to infection in certain sheep populations. Animals homozygous for resistant haplotypes demonstrate lower infection rates when exposed to the virus, though this resistance is not absolute and does not replace biosecurity measures.

Production type considerations influence the practical impact of Maedi-Visna on different sheep operations. Dairy sheep enterprises face particular challenges because the virus causes indurative mastitis that dramatically reduces milk production and may contaminate milk with viral particles. Wool production suffers in infected animals due to poor body condition affecting fiber quality and quantity. Meat lamb production may be less directly impacted if lambs are marketed before clinical disease develops, but infected breeding stock still represents a reservoir of infection affecting flock productivity. Seedstock producers face perhaps the greatest impact, as Maedi-Visna positive status disqualifies animals from sale to negative flocks regardless of apparent health or genetic value.

Genetic selection and testing present important tools for reducing Maedi-Visna susceptibility within sheep flocks over time. Producers with access to genotyping services can identify animals carrying favorable TMEM154 haplotypes and preferentially retain these individuals for breeding. Selecting rams homozygous for resistant alleles and using them across the flock progressively increases resistance gene frequency in subsequent generations. However, genetic selection for disease resistance must be balanced against other selection priorities and should not substitute for biosecurity practices. Combining genetic improvement with traditional test-and-cull approaches offers the most comprehensive strategy for long-term Maedi-Visna reduction while maintaining selection progress in production traits.

Maedi-Visna commonly co-occurs with other chronic health conditions that complicate diagnosis and management. Caseous lymphadenitis, caused by Corynebacterium pseudotuberculosis, frequently affects the same flocks and age groups as Maedi-Visna and can produce internal abscesses affecting respiratory function. Paratuberculosis (Johne's disease) is another chronic wasting condition of sheep that causes progressive weight loss similar to Maedi-Visna. Internal parasitism may accelerate clinical deterioration in Maedi-Visna infected sheep by imposing additional physiological stress. Managing these concurrent conditions requires comprehensive diagnostic workup and integrated treatment approaches.

Several conditions produce clinical signs similar to Maedi-Visna and must be differentiated through appropriate diagnostic testing. Ovine pulmonary adenocarcinoma (jaagsiekte) causes progressive respiratory disease in sheep with a similar chronic course and geographic overlap with Maedi-Visna. Caprine arthritis encephalitis (CAE) in goats is caused by a closely related lentivirus and produces similar clinical manifestations in that species. Bacterial pneumonia may present with respiratory distress but typically has more acute onset and responds to antibiotic therapy. Scrapie, another chronic neurological disease of sheep, requires differentiation from the nervous form of Maedi-Visna through clinical pattern recognition and diagnostic testing.

Complications and sequelae of Maedi-Visna infection extend the condition's impact beyond the primary viral disease. Secondary bacterial pneumonia commonly develops as compromised lung defenses fail to control normal respiratory flora. Mastitis caused by the virus predisposes to secondary bacterial udder infections that may require treatment. Poor body condition increases susceptibility to various opportunistic infections and metabolic disturbances. Pregnancy toxemia may develop more readily in pregnant ewes with compromised nutritional status due to Maedi-Visna. These complications often cause more acute suffering than the slowly progressive underlying viral disease and may precipitate decisions regarding humane euthanasia.